concept

MICROGLIA ACTIVATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MICROGLIA ACTIVATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

681Connections

1Hypotheses

3Analyses

50Outgoing

50Incoming

0Experiments

3Debates

Summary

MICROGLIA ACTIVATION is a concept in neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with ALS, Aging, Als. Connected to 304 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	MICROGLIA ACTIVATION
Key Genes/Proteins	AGING, AKT, ALPHA-SYNUCLEIN, ALZHEIMER, ALZHEIMER DISEASE, ALZHEIMER'S DISEASE
Related Diseases	Aging, Als, ALS, Alzheimer
Related Pathways	Adaptive Immunity, Akt, Amyloid

Wiki Pages (1)

Knowledge base pages for this entity

Microglia Activation Mechanism

mechanism · 3164 words

Pathway Diagram

graph TD
    MICROGLIA_ACTIVATION["MICROGLIA ACTIVATION"]
    MICROGLIA_ACTIVATION -->|"causes"| cognitive_impairment["cognitive impairment"]
    MICROGLIA_ACTIVATION -->|"activates"| Als["Als"]
    MICROGLIA_ACTIVATION -->|"activates"| Ms["Ms"]
    MICROGLIA_ACTIVATION -->|"activates"| Inflammation["Inflammation"]
    MICROGLIA_ACTIVATION -->|"target for"| Senescence["Senescence"]
    MICROGLIA_ACTIVATION -->|"activates"| Stroke["Stroke"]
    MICROGLIA_ACTIVATION -->|"target for"| Hypertension["Hypertension"]
    MICROGLIA_ACTIVATION -->|"activates"| Neuroinflammation["Neuroinflammation"]
    MICROGLIA_ACTIVATION -->|"target for"| Ischemia["Ischemia"]
    CLEC7A["CLEC7A"] -->|"regulates"| MICROGLIA_ACTIVATION
    TSG["TSG"] -->|"inhibits"| MICROGLIA_ACTIVATION
    FYN["FYN"] -->|"activates"| MICROGLIA_ACTIVATION
    COMPLEMENT["COMPLEMENT"] -->|"activates"| MICROGLIA_ACTIVATION
    AGING["AGING"] -->|"activates"| MICROGLIA_ACTIVATION
    CTSB["CTSB"] -->|"activates"| MICROGLIA_ACTIVATION
    MICROGLIA["MICROGLIA"] -->|"activates"| MICROGLIA_ACTIVATION
    NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| MICROGLIA_ACTIVATION
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"activates"| MICROGLIA_ACTIVATION
    PARKINSON["PARKINSON"] -->|"activates"| MICROGLIA_ACTIVATION

Outgoing (310)

Target	Relation	Type	Str
Aging	activates	disease	1.00
MICROGLIA	activates	gene	1.00
Als	activates	disease	1.00
Neurodegeneration	activates	disease	1.00
NEUROINFLAMMATION	activates	gene	1.00
Neuroinflammation	activates	disease	1.00
Inflammation	activates	disease	1.00
NEURON	activates	gene	1.00
Neuroinflammation	causes	process	0.95
INFLAMMATION	associated_with	gene	0.90
Pro-inflammatory Reactive Astrocytes	causes	phenotype	0.90
Dopaminergic Neuron Degeneration	involved_in	process	0.90
Cardiovascular Diseases	associated_with	disease	0.90
TNF-α	upstream_of	protein	0.90
Neuropathic Pain	causes	disease	0.90
Pro-inflammatory Reactive Astrocytes	associated_with	phenotype	0.90
Neuroinflammation	involved_in	process	0.90
Apoptosis	activates	pathway	0.90
TNF	upstream_of	protein	0.88
Neuroinflammation	contributes_to	process	0.88
inflammatory cytokine secretion	promotes	process	0.85
neuronal injury	contributes_to	process	0.85
Parkinson's Disease	contributes_to	disease	0.85
Alzheimer	activates	disease	0.85
Secondary brain injury	associated_with	phenotype	0.85
Myocardial Infarction	associated_with	disease	0.85
Hypertension	associated_with	disease	0.85
Neuroinflammation	mediates	process	0.85
Neurodegeneration	modulates	process	0.85
Ischemia/Reperfusion Injury	associated_with	disease	0.85
White Matter-Associated Microglia Activation	involved_in	process	0.85
Traumatic Brain Injury	associated_with	disease	0.85
Alzheimer's Disease	associated_with	disease	0.85
Neurogenesis	regulates	process	0.85
pro-inflammatory cytokines	upregulates	protein	0.85
Myelination	regulates	process	0.85
HIV-Associated Neurocognitive Disorder	associated_with	disease	0.85
Aging-Associated Changes	mediates	phenotype	0.82
Spinal Cord	expressed_in	cell_type	0.80
cardiovascular disease progression	drives	phenotype	0.80
Astrocyte Activation	precedes	process	0.80
Autophagy	activates	pathway	0.80
Blood-Brain Barrier	activates	pathway	0.80
Alzheimer	therapeutic_target	disease	0.75
Tumor	activates	disease	0.75
Stroke	activates	disease	0.75
Multiple Sclerosis	activates	disease	0.75
Parkinson	activates	disease	0.75
Als	therapeutic_target	disease	0.75
DEPRESSION	activates	gene	0.70

Incoming (371)

Source	Relation	Type	Str
INFLAMMATION	activates	gene	1.00
NEURODEGENERATION	activates	gene	1.00
TNF-Α	activates	gene	1.00
CYTOKINES	activates	gene	1.00
NEURODEGENERATIVE DISEASES	activates	gene	1.00
TNF	activates	gene	1.00
Usp9X Suppression	suppresses	mechanism	0.95
TREM2	activates	protein	0.95
GABAergic Signaling	activates	pathway	0.93
STING	activates	protein	0.92
PHF2	promotes	enzyme	0.90
DAP12	mediates	protein	0.90
116B	inhibits	compound	0.90
sevoflurane	promotes	drug	0.90
AGER	mediates	receptor	0.90
FYN	causes	gene	0.90
AMYLOID BETA	activates	protein	0.90
37069462	mediates	paper	0.90
TFEB	inhibits	protein	0.90
PI3K-Akt	activates	pathway	0.90
Gut Microbiota	causes	process	0.90
amyloid beta	promotes	protein	0.90
AGER	activates	receptor	0.89
gut microbiota	regulates	process	0.88
DNAJB6 overexpression	inhibits	mechanism	0.88
FGF21	modulates	protein	0.88
Aging	associated_with	process	0.85
SQSTM1	modulates	protein	0.85
TREM2	regulates	protein	0.85
TREM2	regulates	gene	0.85
Alpha-Synuclein Oligomers	upregulates	protein	0.85
PI3K-Akt	drives	pathway	0.85
MAPK	activates	pathway	0.85
CCL2	mediates	protein	0.85
Gut Microbiota	modulates	process	0.85
Autophagy Inhibition	associated_with	process	0.85
TET2	inhibits	gene	0.85
IL-3	activates	protein	0.85
MAPK	regulates	pathway	0.85
Lipopolysaccharide	activates	compound	0.85
amyloid-β plaques	drives	compound	0.85
Glucose Metabolism	modulates	pathway	0.85
ERK	regulates	protein	0.85
ALPHA-SYNUCLEIN	activates	protein	0.80
CLEC7A	regulates	gene	0.80
AKT	modulates	protein	0.80
P2RY12	regulates	protein	0.80
HLA-DR	regulates	protein	0.80
APOE	modulates	protein	0.80
NLRP3	inhibits	gene	0.80

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Spinal Cord Microglia Activation State Convergence	0.455	neuroinflammation	Why do clinical manifestations overlap d

Mentioning Analyses (3)

Scientific analyses that reference this entity

Cross-disease neurodegeneration mechanism synthesis

neurodegeneration | 2026-04-28 | 17 hypotheses Top: 0.828

Does tau dendritic missorting persist independently after Aβ clearance, maintain

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.740

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

neurodegeneration | 2026-04-03 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (3)

Multi-agent debates referencing this entity

Which AD, PD, ALS, and FTD mechanisms recur across disease boundaries and yield

closed · Rounds: 4 · Score: 0.72 · 2026-04-28

Does tau dendritic missorting persist independently after Aβ clearance, maintain

closed · Rounds: 4 · Score: 0.65 · 2026-04-25

What gene expression changes in the aging mouse brain predict neurodegenerative

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

Related Research

Hypotheses and analyses mentioning MICROGLIA ACTIVATION in their description or question text

No additional research found